Market Tracker

07/24 6:05pm ET

Exelixis Inc (NASDAQ:EXEL)

During the Trading Day
4.21 +0.43 / +11.38%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.16 -0.05 / -1.19%
 
Volume: 119.0K

Today’s Trading

Previous close3.78
Today’s open3.80
Day’s range3.75 - 4.21
Volume11,875,596
Average volume (3 months)3,659,525
Market cap$735.9M
Dividend yield--
Data as of 3:59pm ET, 07/24/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-17.74%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book10.53

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...-0.22-1.09%
LXRXLexicon Pharmaceutic...-0.06-3.77%
NXTMNxStage Medical Inc-0.21-1.55%
BRLIBio-Reference Labora...+0.05+0.16%
Data as of 4:00pm ET, 07/24/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts